These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 17649741)

  • 1. [Clinical course and effectiveness of combination chemotherapy for primary Hodgkin's disease involving lung and/or pleura].
    Filatova AV
    Vopr Onkol; 2007; 53(1):87-95. PubMed ID: 17649741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pleural lesions in patients with Hodgkin's disease with pulmonary involvement].
    Baĭsogolov GD; Afanasova NV; Shakhtarina SV
    Med Radiol (Mosk); 1991; 36(1):10-6. PubMed ID: 1996047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hodgkin's disease in children: involvement of lung and pleura.
    Kolygin BA; Vesnin AG
    Pediatr Radiol; 1976 Dec; 5(2):75-80. PubMed ID: 1012802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical and radiologic signs of pulmonary and pleural lesions in childhood Hodgkin's disease].
    Kostromina EV; Semenov II; Kolygin BA
    Vopr Onkol; 2002; 48(6):724-7. PubMed ID: 12530275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pleuropulmonary involvement in Hodgkin's disease. Study of a series of 79 cases of Hodgkin's disease].
    de la Cruz Ríos JL; Sueiro Bendito A
    Rev Clin Esp; 1981 Aug 15-31; 162(3-4):115-21. PubMed ID: 7313203
    [No Abstract]   [Full Text] [Related]  

  • 6. Hodgkin's disease of the lung.
    Aghai E; Hertz M; Ramot B; Brenner HJ
    Isr J Med Sci; 1978 Oct; 14(10):1019-25. PubMed ID: 738867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized comparison of ABVD and MOPP/ABV hybrid for the treatment of advanced Hodgkin's disease: report of an intergroup trial.
    Duggan DB; Petroni GR; Johnson JL; Glick JH; Fisher RI; Connors JM; Canellos GP; Peterson BA
    J Clin Oncol; 2003 Feb; 21(4):607-14. PubMed ID: 12586796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unusual radiologic and histologic manifestations of primary pulmonary lymphoma.
    Baccari-Ezzine S; Bouzaidi K; Chelbi E; Ali MB; Ghrairi H
    Asian Cardiovasc Thorac Ann; 2014 Mar; 22(3):362-4. PubMed ID: 24585921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Features of clinical course of combination chemotherapy for liver involvement in Hodgkin's disease].
    Filatova LV
    Vopr Onkol; 2008; 54(2):192-203. PubMed ID: 18522169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Primary Hodgkin disease of the lung].
    Anchisi S; Pugin P; Baur A
    Schweiz Med Wochenschr; 1993 Jan; 123(3):65-6. PubMed ID: 7678941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ABVD versus BEACOPP for Hodgkin's lymphoma when high-dose salvage is planned.
    Viviani S; Zinzani PL; Rambaldi A; Brusamolino E; Levis A; Bonfante V; Vitolo U; Pulsoni A; Liberati AM; Specchia G; Valagussa P; Rossi A; Zaja F; Pogliani EM; Pregno P; Gotti M; Gallamini A; Rota Scalabrini D; Bonadonna G; Gianni AM; ; ;
    N Engl J Med; 2011 Jul; 365(3):203-12. PubMed ID: 21774708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Standard and increased-dose BEACOPP chemotherapy compared with COPP-ABVD for advanced Hodgkin's disease.
    Diehl V; Franklin J; Pfreundschuh M; Lathan B; Paulus U; Hasenclever D; Tesch H; Herrmann R; Dörken B; Müller-Hermelink HK; Dühmke E; Loeffler M;
    N Engl J Med; 2003 Jun; 348(24):2386-95. PubMed ID: 12802024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effectiveness and toxicity of MOPP, ABVD, BEACOPP chemotherapy in first-diagnosed Hodgkin lymphoma with a poor prognosis].
    Filatova LV; Plotnikova AA; Gershanovich ML; Semiglazova TIu
    Vopr Onkol; 2013; 59(2):59-65. PubMed ID: 23814851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Characteristics of the formation, course and outcome of lymphogranulomatous caverns in the lungs].
    Semenov II; Trishkina EA
    Vopr Onkol; 1981; 27(5):38-44. PubMed ID: 7245671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemotherapy plus involved-field radiation in early-stage Hodgkin's disease.
    Fermé C; Eghbali H; Meerwaldt JH; Rieux C; Bosq J; Berger F; Girinsky T; Brice P; van't Veer MB; Walewski JA; Lederlin P; Tirelli U; Carde P; Van den Neste E; Gyan E; Monconduit M; Diviné M; Raemaekers JM; Salles G; Noordijk EM; Creemers GJ; Gabarre J; Hagenbeek A; Reman O; Blanc M; Thomas J; Vié B; Kluin-Nelemans JC; Viseu F; Baars JW; Poortmans P; Lugtenburg PJ; Carrie C; Jaubert J; Henry-Amar M;
    N Engl J Med; 2007 Nov; 357(19):1916-27. PubMed ID: 17989384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Combined-modality therapy for 150 cases of early-stage Hodgkin's lymphoma].
    Niu Y; Shi YK; He XH; Feng FY; Zhou LQ; Gu DZ
    Zhonghua Zhong Liu Za Zhi; 2008 Aug; 30(8):630-4. PubMed ID: 19102946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical x-ray comparisons in the intrathoracic localization of lymphogranulomatosis and non-Hodgkin lymphomas].
    Simbirtseva LP; Shedakov AA; Shust VF; Davydova SB
    Vopr Onkol; 1986; 32(1):50-5. PubMed ID: 3753812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Omission of dacarbazine or bleomycin, or both, from the ABVD regimen in treatment of early-stage favourable Hodgkin's lymphoma (GHSG HD13): an open-label, randomised, non-inferiority trial.
    Behringer K; Goergen H; Hitz F; Zijlstra JM; Greil R; Markova J; Sasse S; Fuchs M; Topp MS; Soekler M; Mathas S; Meissner J; Wilhelm M; Koch P; Lindemann HW; Schalk E; Semrau R; Kriz J; Vieler T; Bentz M; Lange E; Mahlberg R; Hassler A; Vogelhuber M; Hahn D; Mezger J; Krause SW; Skoetz N; Böll B; von Tresckow B; Diehl V; Hallek M; Borchmann P; Stein H; Eich H; Engert A; ; ;
    Lancet; 2015 Apr; 385(9976):1418-27. PubMed ID: 25539730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The risk of acute leukemia in patients treated for Hodgkin's disease is significantly higher aft [see bined modality programs than after chemotherapy alone and is correlated with the extent of radiotherapy and type and duration of chemotherapy: a case-control study.
    Brusamolino E; Anselmo AP; Klersy C; Santoro M; Orlandi E; Pagnucco G; Lunghi F; Maurizi-Enrici R; Baroni CD; Lazzarino M; Mandelli F; Bernasconi C
    Haematologica; 1998 Sep; 83(9):812-23. PubMed ID: 9825578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of advanced Hodgkin's disease.
    Straus DJ
    Hematol Oncol Clin North Am; 1989 Jun; 3(2):287-302. PubMed ID: 2473061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.